tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial
PremiumCompany AnnouncementsPolyPid Secures $26.7 Million Post-Successful Phase 3 Trial
29d ago
PolyPid price target lowered to $14 from $16 at Citizens JMP
Premium
The Fly
PolyPid price target lowered to $14 from $16 at Citizens JMP
29d ago
PolyPid price target raised to $13 from $11 at H.C. Wainwright
Premium
The Fly
PolyPid price target raised to $13 from $11 at H.C. Wainwright
1M ago
PolyPid initiated with a Buy at Roth Capital
PremiumThe FlyPolyPid initiated with a Buy at Roth Capital
1M ago
PolyPid’s D-PLEX100 and PLEX Technology: A Promising Buy Amidst Upcoming Phase 3 SHIELD II Trial
Premium
Ratings
PolyPid’s D-PLEX100 and PLEX Technology: A Promising Buy Amidst Upcoming Phase 3 SHIELD II Trial
1M ago
PolyPid assumed with a Buy at H.C. Wainwright
Premium
The Fly
PolyPid assumed with a Buy at H.C. Wainwright
1M ago
PolyPid management to meet virtually with Craig-Hallum
PremiumThe FlyPolyPid management to meet virtually with Craig-Hallum
2M ago
PolyPid Completes Enrollment in Phase 3 Trial of D-PLEX100
Premium
Company Announcements
PolyPid Completes Enrollment in Phase 3 Trial of D-PLEX100
2M ago
PolyPid reports Q1 EPS 70c vs $1.37 last year
Premium
The Fly
PolyPid reports Q1 EPS 70c vs $1.37 last year
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100